ERC Starting Grant · 2024
Antimicrobial resistance is a burning global issue. The available antimicrobials are losing efficacy as resistant bacteria arise, but the industry does not invest enough into antibiotic discovery due to low expected revenues. Natural antimicrobial peptides (AMPs) hold great promise as blueprints for new antibiotics. However, there are few known natural AMPs with sufficiently high potency and low toxicity that enable applications in veterinary and human medicine. As a result, the research on natural peptide antibiotics has been obstructed. New natural AMPs are needed urgently. I propose for the first time that picobodies, recently discovered peptides part of natural cow antibodies, have…
From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.